Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure-Reference-Cited by-同舟云学术

Re‐biopsy and liquid biopsy for patients with non‐small cell lung cancer after EGFR‐tyrosine kinase inhibitor failure

Published:2019-03-18 Issue:4 Volume:10 Page:957-965
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Zhou Juan¹^ORCID,Zhao Chao²,Zhao Jing¹,Wang Qi¹,Chu Xiangling¹,Li Jiayu¹,Zhou Fei¹,Ren Shengxiang¹^ORCID,Li Xuefei²,Su Chunxia¹,Zhou Caicun¹

Affiliation:

1. Department of Medical Oncology, Shanghai Pulmonary Hospital & Thoracic Cancer InstituteTongji University School of Medicine Shanghai China

2. Department of Lung Cancer and Immunology, Shanghai Pulmonary Hospital & Thoracic Cancer InstituteTongji University School of Medicine Shanghai China

Funder

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13035

Reference35 articles.

1. Cancer statistics in China, 2015

2. Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

3. Lung Cancer

4. Advances in the Development of Molecularly Targeted Agents in Non-Small-Cell Lung Cancer

5. Personalized medicine in non-small cell lung cancer: a review from a pharmacogenomics perspective

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimizing ctDNA: An Updated Review of a Promising Clinical Tool for the Management of Uveal Melanoma;Cancers;2024-09-01

2. Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC;Scientific Reports;2024-01-03

3. Recent advances in droplet‐based microfluidics in liquid biopsy for cancer diagnosis;Droplet;2024-01

4. Machine learning-based radiomics strategy for prediction of acquired EGFR T790M mutation following treatment with EGFR-TKI in NSCLC;2023-10-23

5. Re‐re‐biopsy? How much tumor is enough in the era of precision oncology?;Asia-Pacific Journal of Clinical Oncology;2023-10-02